Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel

Intrinsic or acquired chemoresistance is a hurdle in oncology. Only 7%–16% of estrogen receptor α (ERα) positive breast cancer cases achieve a pathological complete response (pCR) after neo-adjuvant chemotherapy. Nogo-B receptor (NgBR) is a cell surface receptor that binds farnesylated Ras and promo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Lett
Autors principals: Jin, Ying, Hu, Wenquan, Liu, Tong, Rana, Ujala, Aguilera-Barrantes, Irene, Kong, Amanda, Kumar, Suresh N., Wang, Bei, Gao, Pin, Wang, Xiang, Duan, Yajun, Shi, Aiping, Song, Dong, Yang, Ming, Li, Sijie, Han, Bing, Zhao, Gang, Fan, Zhimin, Miao, Qing Robert
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821135/
https://ncbi.nlm.nih.gov/pubmed/29373839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.01.054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars